Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis by L. De Giglio, F. Marinelli, L. Prosperini, G. M. Contessa, F. Gurreri, M. C. Piattella, F. De Angelis, V. T. Barletta, V. Tomassini, P. Pantano, C. Pozzilli

“…The role of prolactin (PRL) on tissue injury and repair mechanisms in multiple sclerosis (MS) remains unclear. The aim of this work was to investigate the relationship between PRL plasma levels and brain damage as measured by magnetic resonance imaging (MRI). …”
Get full text

Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis by Suhail Al-Shammri, Suhail Al-Shammri, Arpita Chattopadhyay, Abu Salim Mustafa

Subjects: “…multiple sclerosis…”
Get full text

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability by S. Migliore, A. Ghazaryan, I. Simonelli, P. Pasqualetti, F. Squitieri, G. Curcio, D. Landi, M. G. Palmieri, F. Moffa, M. M. Filippi, F. Vernieri

“…Cognitive dysfunction affects 40–65% of multiple sclerosis (MS) patients and can occur in the early stages of the disease. …”
Get full text

Costs of Potential Medication Wastage Due to Switching Treatment Among People With Multiple Sclerosis by Darin T. Okuda, Achal Patel, Robert Schuldt, Ibraheem Abioye, Nicole G. Bonine

“…**Background:** Unused medications negatively impact healthcare resource utilization and environmental safety, contribute substantially to annual healthcare expenditures, and may ultimately affect patient health outcomes. People with multiple sclerosis (PwMS) commonly switch disease-modifying therapies (DMTs), leading to medication wastage and substantial costs for insurers and patients. …”
Get full text

Decrease of Mutual Information in Brain Electrical Activity of Patients with Relapsing-Remitting Multiple Sclerosis by Bruno Lenne, Jean-Luc Blanc, Jean-Louis Nandrino, Philippe Gallois, Patrick Hautecæur, Laurent Pezard

“…Cortical communication is quantified here in control subjects and patients with relapsing-remitting multiple sclerosis (RRMS) on the basis of mean coherence in the δ, θ, α, β and γ bands and using mutual information computed between pairs of bipolar EEG signals recorded during resting condition. …”
Get full text

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis by Vinzenz Fleischer, Tobias Brummer, Muthuraman Muthuraman, Muthuraman Muthuraman, Falk Steffen, Milena Heldt, Maria Protopapa, Muriel Schraad, Gabriel Gonzalez-Escamilla, Sergiu Groppa, Stefan Bittner, Frauke Zipp

Subjects: “…multiple sclerosis…”
Get full text

Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis by Véronique Ferret-Sena, Alexandra Maia e Silva, Armando Sena, Inês Cavaleiro, José Vale, Bruno Derudas, Giulia Chinetti-Gbaguidi, Bart Staels

“…Peroxisome Proliferator-Activated Receptors (PPAR) are transcription factors suggested to be involved in inflammatory lesions of autoimmune encephalomyelitis and multiple sclerosis (MS). Our objective was to assess whether Natalizumab (NTZ) therapy is associated with alterations of PPAR expression in MS patients. …”
Get full text

Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis by Elisabetta Volpe, Luca Battistini, Giovanna Borsellino

“…The discovery of the T helper (Th) 17 lineage, involved in the protection against fungal and extracellular bacterial infections, has profoundly revolutionized our current understanding of T cell-mediated responses in autoimmune diseases, including multiple sclerosis (MS). Indeed, recent data demonstrate the pathogenic role of Th17 cells in autoimmune disorders. …”
Get full text

Inflammatory proteins related to depression in multiple sclerosis: A systematic review and meta-analysis by L.A. Kiropoulos, V. Rozenblat, N. Baes

Subjects: Get full text

Optic neuritis by J. Katelytė, R. Liutkevičienė

Subjects: Get full text

Corrigendum to “A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis” by I. I. Kneebone, S. Guerrier, E. Dunmore, E. Jones, C. Fife-Schaw

Get full text

Antibody Response in Seropositive Multiple Sclerosis Patients Vaccinated with Attenuated Live Varicella Zoster Virus by RT Ross, MR Dawood, Mary Cheang, Lindsay E Nicolle

“…OBJECTIVE: To determine the safety and effectiveness of live attenuated varicella zoster virus (VZV) vaccine (OKA/Merck) on 50 patients with chronic progressive multiple sclerosis (MS), based on the hypothesis that VZV might be the antigen or antigen mimic of MS plus the fact that repeated high antigen doses have produced ‘antigen paralysis’ in experimental allergic encephalomyelitis mice.…”
Get full text

Does Pain in Individuals with Multiple Sclerosis Affect Employment? A Systematic Review and Meta-Analysis by Shahnaz Shahrbanian, Mohammad Auais, Pierre Duquette, Katie Anderson, Nancy E Mayo

“…BACKGROUND: Individuals with multiple sclerosis (MS) experience some of the highest unemployment rates among all groups of chronic illnesses. …”
Get full text

The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity by Barry Hendin, Richard A. Brook, Ian A. Beren, Nathan Kleinman, Cindy Fink, Amy L. Phillips, Carroline Lobo

“…**Background:** Research on employee care partners of patients with multiple sclerosis (MS) is limited. **Objectives:** The clinical and economic impact on employee care partners was evaluated by MS disease severity. …”
Get full text

Mediational Model of Multiple Sclerosis Impairments, Family Needs, and Caregiver Mental Health in Guadalajara, Mexico by Melody N. Mickens, Paul B. Perrin, Adriana Aguayo, Brenda Rabago, Miguel A. Macías-Islas, Juan Carlos Arango-Lasprilla

“…Individuals with multiple sclerosis (MS), especially those living in Latin America, often require assistance from family caregivers throughout the duration of the disease. …”
Get full text

Pediatric Multiple Sclerosis—A Challenging Demyelinating Disease: Case Report and Brief Review of the Literature by Regina Célia Ajeje Pires de Albuquerque, Raquel Siqueira Leonel de Paula, Manuelina Mariana Capellari Macruz Brito, José Roberto Lopes Ferraz Filho, Lucas Crociati Meguins

“…Multiple sclerosis (MS) is an inflammatory, demyelinating, neurodegenerative disorder of the central nervous system (CNS) of unknown etiology. …”
Get full text

Survey on first-line therapeutic management of relapsing–remitting multiple sclerosis in clinical practice in Spain by M. Llaneza, G. Fontes, L. Benedito-Palos, E. Moral

“…Introduction: Current therapies for relapsing–remitting multiple sclerosis (RRMS) help reduce morbidity and delay disease progression. …”
Get full text

Functional Evaluation of the Visual Pathway in Patients with Multiple Sclerosis Using a Multifunction Stimulator Monitor by M. Satue, L. Jarauta, J. Obis, M. Cipres, M. J. Rodrigo, C. Almarcegui, I. Dolz, J. R. Ara, J. Martin, L. E. Pablo, E. Garcia-Martin

“…This device may be a fast and useful tool to provide a full evaluation of axonal damage in patients with multiple sclerosis.…”
Get full text

Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives by Qingqing Zhou, Rui Jia, Jingxia Dang

“…Multiple sclerosis (MS) is a chronic debilitating immune-mediated disease of the central nervous system, which causes demyelination and neuroaxonal damage. …”
Get full text

Biofilm Formation of Staphylococcus Aureus in Multiple Sclerosis Patients and its Essential Role in the Pathogenicity of the Disease by Suhad Hassan Aubaid, Ekhlas Saddam Falih, Suhaib khalid Ibrahim

Subjects: “…Multiple sclerosis Staphylococcus aureus…”
Get full text